Alpha-synuclein preformed fibrils: a tool to understand Parkinson’s disease and develop disease modifying therapy
- 25 March 2021
- journal article
- Published by Medknow in Neural Regeneration Research
- Vol. 16 (11), 2219-2221
- https://doi.org/10.4103/1673-5374.310686
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- Brain-first versus body-first Parkinson’s disease: a multimodal imaging case-control studyBrain, 2020
- Impact of α-synuclein pathology on transplanted hESC-derived dopaminergic neurons in a humanized α-synuclein rat model of PDProceedings of the National Academy of Sciences of the United States of America, 2020
- α-Synuclein aggregation nucleates through liquid–liquid phase separationNature Chemistry, 2020
- Bidirectional gut-to-brain and brain-to-gut propagation of synucleinopathy in non-human primatesBrain, 2020
- Serum neuronal exosomes predict and differentiate Parkinson’s disease from atypical parkinsonismJournal of Neurology, Neurosurgery & Psychiatry, 2020
- Initiation and propagation of α-synuclein aggregation in the nervous systemMolecular Neurodegeneration, 2020
- The process of Lewy body formation, rather than simply α-synuclein fibrillization, is one of the major drivers of neurodegenerationProceedings of the National Academy of Sciences of the United States of America, 2020
- Back and to the Future: From Neurotoxin‐Induced to Human Parkinson's Disease ModelsCurrent Protocols in Neuroscience, 2020
- Discriminating α-synuclein strains in Parkinson’s disease and multiple system atrophyNature, 2020
- Lewy pathology in Parkinson’s disease consists of crowded organelles and lipid membranesNature Neuroscience, 2019